JPS58150580A - ベンゾチアゼピン誘導体の製造法 - Google Patents
ベンゾチアゼピン誘導体の製造法Info
- Publication number
- JPS58150580A JPS58150580A JP3432082A JP3432082A JPS58150580A JP S58150580 A JPS58150580 A JP S58150580A JP 3432082 A JP3432082 A JP 3432082A JP 3432082 A JP3432082 A JP 3432082A JP S58150580 A JPS58150580 A JP S58150580A
- Authority
- JP
- Japan
- Prior art keywords
- acetoxy
- dihydro
- compound
- alkali
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007657 benzothiazepines Chemical class 0.000 title 1
- 239000003513 alkali Substances 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 10
- 150000001875 compounds Chemical class 0.000 abstract description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract description 3
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 3
- 125000000217 alkyl group Chemical group 0.000 abstract description 3
- 238000005804 alkylation reaction Methods 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 abstract description 2
- 150000001350 alkyl halides Chemical class 0.000 abstract description 2
- 230000002152 alkylating effect Effects 0.000 abstract description 2
- 150000008050 dialkyl sulfates Chemical class 0.000 abstract description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 abstract description 2
- 239000012312 sodium hydride Substances 0.000 abstract description 2
- 229910000104 sodium hydride Inorganic materials 0.000 abstract description 2
- 230000029936 alkylation Effects 0.000 abstract 2
- 102400001284 Vessel dilator Human genes 0.000 abstract 1
- XJLFPKWZYCQIRJ-UHFFFAOYSA-N [4-(4-oxo-3,5-dihydro-2h-1,5-benzothiazepin-2-yl)phenyl] acetate Chemical class C1=CC(OC(=O)C)=CC=C1C1SC2=CC=CC=C2NC(=O)C1 XJLFPKWZYCQIRJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000013019 agitation Methods 0.000 abstract 1
- 108010090012 atrial natriuretic factor prohormone (31-67) Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 210000004351 coronary vessel Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000004089 psychotropic agent Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940100198 alkylating agent Drugs 0.000 description 3
- 239000002168 alkylating agent Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- -1 Potassium tertiary butoxy, sodium tertiary butoxy, sodium hydride Chemical compound 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 150000004701 malic acid derivatives Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- JREYOWJEWZVAOR-UHFFFAOYSA-N triazanium;[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].CC(=C)CCOP([O-])(=O)OP([O-])([O-])=O JREYOWJEWZVAOR-UHFFFAOYSA-N 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Landscapes
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3432082A JPS58150580A (ja) | 1982-03-03 | 1982-03-03 | ベンゾチアゼピン誘導体の製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3432082A JPS58150580A (ja) | 1982-03-03 | 1982-03-03 | ベンゾチアゼピン誘導体の製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58150580A true JPS58150580A (ja) | 1983-09-07 |
| JPS6342623B2 JPS6342623B2 (enrdf_load_stackoverflow) | 1988-08-24 |
Family
ID=12410863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3432082A Granted JPS58150580A (ja) | 1982-03-03 | 1982-03-03 | ベンゾチアゼピン誘導体の製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58150580A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06144564A (ja) * | 1992-11-13 | 1994-05-24 | Daifuku Co Ltd | クリーンルーム用搬送設備 |
-
1982
- 1982-03-03 JP JP3432082A patent/JPS58150580A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6342623B2 (enrdf_load_stackoverflow) | 1988-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Weil et al. | A simplified procedure for the preparation of diazocyclopentadiene and some related compounds | |
| EP0128684A1 (en) | Process for producing 3-(3,4-dihydroxyphenyl) serine | |
| SU873887A3 (ru) | Способ получени производных имидазо/2,1-в/тиазолина или имидазо /2,1-в/тиазина или их кислотно-аддитивных солей,в виде смеси изомеров или отдельных изомеров | |
| JP3030780B2 (ja) | 光学活性なケテンジチオアセタール誘導体及びその製造方法 | |
| JPH07179389A (ja) | ５，８−ジクロロ−１，４，９，１０−アントラセンテトロン | |
| CA1202974A (fr) | Procede de preparation de nouvelles benzothiopyranopyridinones et de leurs sels | |
| JPS58150580A (ja) | ベンゾチアゼピン誘導体の製造法 | |
| FI68828B (fi) | Foerfarande foer framstaellning av nya neuroleptiska 2-(aminoalkyl)-5-fenyl-2,3,4,4a,5,9b-hexahydro-4a,9b-trans-1h-pyrido(4,3-b)indolderivat | |
| EP0718299B1 (fr) | Ethers d'oximes tricycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| JP2007513185A (ja) | チューブリンのインヒビターの調製のためのプロセス | |
| DE69818988T2 (de) | 9,10-diazatryclo[4.2.11 2,5]decan- und 9,10-diazatricyclo[3.3.1.1 2,6]decanderive mit analgetischer wirkung | |
| ATE37365T1 (de) | (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamine, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| JPS62252789A (ja) | ベンゾチオピラノ〔４，３−ｃ〕ピリダジン化合物 | |
| US5097059A (en) | Resolution process of intermediates useful for the preparation of diltiazem | |
| JPS623150B2 (enrdf_load_stackoverflow) | ||
| JPH06122686A (ja) | ラセミ体の光学分割法 | |
| CH642634A5 (en) | 1-Phenyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1H-3-benzazepines | |
| SU953980A3 (ru) | Способ получени замещенных производных хинолизидина или индолизидина ,или их солей, или четвертичных солей | |
| US3118905A (en) | N-(haloalkyl)-endo-perhydro-4, 7-methanoisoindoles | |
| JP2007522152A (ja) | メチル−α−５−［４，５，６，７−テトラヒドロ［３，２−Ｃ］チエノピリジル］−（２−クロロフェニル）アセテートのラセミ化合物の分割 | |
| AT394367B (de) | Verfahren zur herstellung eines 1,5-benzothiazepinderivates oder eines salzes davon | |
| ES2857128T3 (es) | Procedimiento para la síntesis de firocoxib | |
| CH633555A5 (de) | Verfahren zur herstellung von 1-(2-(dialkylamino)aethyl)-6-aryl-4h-s-triazolo(4,3-a)(1,4)benzodiazepinen. | |
| FR2606017A1 (fr) | Derives cycliques condenses du triazole, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation comme sedatif et tranquilisant | |
| AT395424B (de) | Verfahren zur herstellung von neuen 1,5-benzothiazepinderivaten |